Quantcast

Latest HPV Stories

2014-05-07 20:24:22

LONDON, May 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwidehttp://www.reportbuyer.com/pharma_healthcare/diagnostics/cervical_cancer_test_market_patients_pap_smear_hpv_dna_via_test_patients_worldwide.htmlCervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has...

2014-05-05 20:27:53

LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Molecular Diagnostics in Infectious Disease Testinghttp://www.reportbuyer.com/pharma_healthcare/diagnostics/molecular_diagnostics_infectious_disease_testing.htmlThis TriMark Publications report describes the specific segment of the in vitro diagnostics market known as molecular diagnostics testing for infectious disease. In the current medical diagnostics market, molecular diagnostics in...

2014-04-24 16:29:10

Expanded indication makes cobas® HPV Test the only test approved in U.S. that can be used instead of Pap in first-line primary screening in women 25 and older PLEASANTON, Calif., April 24, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY)announced today that the U.S. Food and Drug Administration (FDA) approved the cobas(®) HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The approval follows the March 12...

2014-04-23 12:30:36

LONDON, April 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/drug_discovery/human_papillomavirus_hpv_associated_cancer_global_clinical_trials_review_h1_2014.html Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014 SummaryGlobalData's clinical trial report, "Human papillomavirus (HPV)...

2014-04-16 08:30:31

GERMANTOWN, Md., April 16, 2014 /PRNewswire/ -- -- Investment of $10 million in Germantown and Frederick campuses brings QIAGEN's total recent commitment in Maryland to $50 million -- Germantown campus becomes state-of-the-art research, manufacturing and office site for Molecular Diagnostics with consolidation of activities from Gaithersburg site -- Germantown site passes FDA pre-approval inspection to manufacture digene HC2 HPV Test --...

2014-04-15 12:28:49

RnRMarketResearch.com adds "Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide" to its store. DALLAS, April 15, 2014 /PRNewswire-iReach/ -- This report provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 232 page report with 240 Figures and 14 Table provides a complete analysis of top 20 Countries Cervical Cancer Test Market & Population. All the 20 countries in the report...

2014-04-08 00:22:15

Research efforts will investigate approaches to develop novel immune therapies for HPV-associated cancers SAN DIEGO, April 7, 2014 /PRNewswire-USNewswire/ -- Stand Up To Cancer (SU2C) and the Farrah Fawcett Foundation, along with the American Association for Cancer Research (AACR), SU2C's Scientific Partner, announced the formation of a research team dedicated to HPV-related cancers during a press event today at the AACR Annual Meeting 2014, held here April 5-9. The HPV and Anal Cancer...

2014-04-07 15:53:35

Patients with cancer of the throat and who are positive for the Human Papilloma virus (HPV+) have a good prognosis, but until now the effect of being HPV+ on the prognosis of tumors located elsewhere in the head and neck was unknown. Danish researchers have now shown that HPV status appears to have no prognostic effect on the outcome of primary radiotherapy in head and neck cancer outside the oropharynx (the part of the throat located behind the mouth, and which contains the soft palate and...

2014-04-02 08:32:24

Xpert HPV is the Only Test Capable of Reporting High-risk Human Papillomavirus DNA in Captured Cervical Cells SUNNYVALE, Calif., April 2, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced the release of Xpert(®) HPV, a 60-minute test for cervical cancer-related human papillomaviruses to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on Cepheid's GeneXpert(®) System, the world's leading molecular diagnostic...

2014-04-01 23:00:05

RnRMarketResearch.com adds Latest Report on “Cervical Cancer Test Market & Patients – Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide” to its store. Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=162886 Dallas, TX (PRWEB) April 02, 2014 This report provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This report provides a complete analysis of top 20...


Latest HPV Reference Libraries

0_d7e189bb6feb0f5663af7d072b6f51c6
2011-02-17 14:56:32

A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...

More Articles (1 articles) »
Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin